stockportfolio.pro
Inspire Medical Systems, Inc. (INSP)
Healthcare · Medical Devices · NYSE
Inspire Medical Systems, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.43M | $28.57M | $50.59M | $82.05M | $115.38M | $233.39M | $407.86M | $624.80M | $802.80M | $911.98M |
| Gross profit | $12.52M | $22.55M | $40.54M | $68.41M | $97.76M | $200.12M | $341.74M | $528.22M | $679.82M | $778.76M |
| Net income | $-18.53M | $-17.51M | $-21.83M | $-33.24M | $-57.20M | $-42.04M | $-44.88M | $-21.15M | $53.51M | $145.42M |
| Net margin | -112.8% | -61.3% | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% |
Source: Inspire Medical Systems, Inc. SEC filings (10-K).
What growth is priced into INSP stock?
At today's market cap of $1.22B, Inspire Medical Systems, Inc. is priced for free-cash-flow growth of about 4.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $78.48M from the FY ending 2025-12-31). For comparison, revenue 51.2%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 10 years of Inspire Medical Systems, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track INSP in your portfolio →
Inspire Medical Systems, Inc. financial history by metric
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc. — frequently asked questions
What is Inspire Medical Systems, Inc.'s revenue?
Inspire Medical Systems, Inc. (INSP) reported revenue of $911.98M for fiscal year 2025, up 13.6% from the prior year, according to its SEC filings.
Is Inspire Medical Systems, Inc. profitable?
Yes. INSP earned net income of $145.42M in fiscal 2025, a net margin of 15.9%.
What is INSP's P/E ratio?
Inspire Medical Systems, Inc. trades at a price-to-earnings ratio of about 9.6 based on the latest data in our nightly-refreshed cache.
How fast is Inspire Medical Systems, Inc. growing?
INSP's revenue grew at roughly 51.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Inspire Medical Systems, Inc. have?
As of fiscal year 2025, INSP carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Inspire Medical Systems, Inc.'s gross margin?
INSP's gross margin was 85.4% in fiscal 2025 — gross profit of $778.76M on revenue of $911.98M.
What is Inspire Medical Systems, Inc.'s market cap?
Inspire Medical Systems, Inc. (INSP) has a market capitalization of about $1.22B, based on the latest data in our nightly-refreshed cache.
When does Inspire Medical Systems, Inc.'s fiscal year end?
INSP's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into INSP stock?
At today's market cap of $1.22B, Inspire Medical Systems, Inc. is priced for free-cash-flow growth of about 4.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $78.48M from the FY ending 2025-12-31). For comparison, revenue 51.2%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Inspire Medical Systems, Inc.'s official SEC filings (10-K and 10-Q), covering 10 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.